317 related articles for article (PubMed ID: 19073408)
1. Ammonia metabolism capacity of HepG2 cells with high expression of human glutamine synthetase.
Tang NH; Wang XQ; Li XJ; Chen YL
Hepatobiliary Pancreat Dis Int; 2008 Dec; 7(6):621-7. PubMed ID: 19073408
[TBL] [Abstract][Full Text] [Related]
2. [Inhibitory effect of blocking expression of human augmenter of liver regeneration (hALR) on proliferation of hepatocellular carcinoma cell line HepG2].
Tang L; Sun H; Zhang L; Guo H; Zhang L; Liu Q
Ai Zheng; 2006 Jun; 25(6):671-6. PubMed ID: 16764759
[TBL] [Abstract][Full Text] [Related]
3. In vivo estimation of bioartificial liver with recombinant HepG2 cells using pigs with ischemic liver failure.
Enosawa S; Miyashita T; Fujita Y; Suzuki S; Amemiya H; Omasa T; Hiramatsu S; Suga K; Matsumura T
Cell Transplant; 2001; 10(4-5):429-33. PubMed ID: 11549067
[TBL] [Abstract][Full Text] [Related]
4. Potential role of novel hepatocellular carcinoma-associated gene IDD01 in promoting tumorigenesis of HepG2 cell line.
Chen XY; Li JS; Ma J; Duan FL; Zhong P
Chin Med J (Engl); 2006 Oct; 119(20):1709-14. PubMed ID: 17097018
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous recovery of dual pathways for ammonia metabolism do not improve further detoxification of ammonia in HepG2 cells.
Zhang FY; Tang NH; Wang XQ; Li XJ; Chen YL
Hepatobiliary Pancreat Dis Int; 2013 Oct; 12(5):525-32. PubMed ID: 24103284
[TBL] [Abstract][Full Text] [Related]
6. [Effects of COX-2 gene silencing by shRNA on biological characteristics of human hepatocellular carcinoma cell line HepG2].
Xu KS; Wang HF; Qian W; Wang BH
Ai Zheng; 2007 Jan; 26(1):32-7. PubMed ID: 17222364
[TBL] [Abstract][Full Text] [Related]
7. Anti-tumor effect of recombinant retroviral vector-mediated human ANGPTL4 gene transfection.
Li KQ; Li WL; Peng SY; Shi XY; Tang HL; Liu YB
Chin Med J (Engl); 2004 Sep; 117(9):1364-9. PubMed ID: 15377430
[TBL] [Abstract][Full Text] [Related]
8. [Killing effect of PNP/MeP-dR suicide gene system driven by an AFP promoter AF0.3 on AFP-positive hepatoma cells].
Cai XK; Zhou JL; Zhou HJ; Zhang L; Wu JH; Lin JS
Ai Zheng; 2006 Nov; 25(11):1334-9. PubMed ID: 17094897
[TBL] [Abstract][Full Text] [Related]
9. Expression of glutamine synthetase and carbamoylphosphate synthetase i in a bioartificial liver: markers for the development of zonation in vitro.
Poyck PP; Hoekstra R; Vermeulen JL; van Wijk AC; Chamuleau RA; Hakvoort TB; van Gulik TM; Lamers WH
Cells Tissues Organs; 2008; 188(3):259-69. PubMed ID: 18354250
[TBL] [Abstract][Full Text] [Related]
10. Cells for bioartificial liver devices: the human hepatoma-derived cell line C3A produces urea but does not detoxify ammonia.
Mavri-Damelin D; Damelin LH; Eaton S; Rees M; Selden C; Hodgson HJ
Biotechnol Bioeng; 2008 Feb; 99(3):644-51. PubMed ID: 17680661
[TBL] [Abstract][Full Text] [Related]
11. Direct molecular and spectroscopic evidence for increased ammonia removal capacity of skeletal muscle in acute liver failure.
Chatauret N; Desjardins P; Zwingmann C; Rose C; Rao KV; Butterworth RF
J Hepatol; 2006 Jun; 44(6):1083-8. PubMed ID: 16530878
[TBL] [Abstract][Full Text] [Related]
12. Characteristic gene expression induced by polyurethane foam/spheroid culture of hepatoma cell line, Hep G2 as a promising cell source for bioartificial liver.
Shimada M; Yamashita Y; Tanaka S; Shirabe K; Nakazawa K; Ijima H; Sakiyama R; Fukuda J; Funatsu K; Sugimachi K
Hepatogastroenterology; 2007; 54(75):814-20. PubMed ID: 17591070
[TBL] [Abstract][Full Text] [Related]
13. Ornithine transcarbamylase and arginase I deficiency are responsible for diminished urea cycle function in the human hepatoblastoma cell line HepG2.
Mavri-Damelin D; Eaton S; Damelin LH; Rees M; Hodgson HJ; Selden C
Int J Biochem Cell Biol; 2007; 39(3):555-64. PubMed ID: 17098461
[TBL] [Abstract][Full Text] [Related]
14. [Effect of overexpression of glycosylphosphatidylinositol-specific phospholipase D on biological character of hepatocellular carcinoma cell line HepG2].
He WJ; Tang JH; Tan CC; Duan Q; Wang KJ; Zuo KQ; Yuan XY
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Feb; 33(2):103-9. PubMed ID: 18326903
[TBL] [Abstract][Full Text] [Related]
15. Enzyme activity analysis of CYP2C18 with exon 5 skipped.
Zhu-Ge J; Yu YN
Acta Pharmacol Sin; 2004 Aug; 25(8):1065-9. PubMed ID: 15301741
[TBL] [Abstract][Full Text] [Related]
16. [Diclofenac suppresses hepatoma cell proliferation and promotes cyclooxygenase-2 mRNA expression].
Chen NN; Wu SG
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):814-7. PubMed ID: 16793607
[TBL] [Abstract][Full Text] [Related]
17. The newly established human hepatocyte cell line: application for the bioartificial liver.
Harimoto N; Taketomi A; Kitagawa D; Kuroda Y; Itoh S; Gion T; Tanaka S; Shirabe K; Shimada M; Maehara Y
J Hepatol; 2005 Apr; 42(4):557-64. PubMed ID: 15763342
[TBL] [Abstract][Full Text] [Related]
18. Acetaldehyde-induced growth retardation and micro-heterogeneity of the sugar chain in transferrin synthesized by HepG2 cells.
Searashi Y; Yamauchi M; Sakamoto K; Ohata M; Asakura T; Ohkawa K
Alcohol Clin Exp Res; 2002 Aug; 26(8 Suppl):32S-37S. PubMed ID: 12198372
[TBL] [Abstract][Full Text] [Related]
19. Changes in S-adenosylmethionine synthetase in human liver cancer: molecular characterization and significance.
Cai J; Sun WM; Hwang JJ; Stain SC; Lu SC
Hepatology; 1996 Nov; 24(5):1090-7. PubMed ID: 8903381
[TBL] [Abstract][Full Text] [Related]
20. [Studies on regulation of glutamine synthetase activity from Streptomyces lincolnensis].
Jin Z; Jiao R; Mao Y
Wei Sheng Wu Xue Bao; 2001 Aug; 41(4):481-8. PubMed ID: 12552916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]